Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Mar 22;2018(3):omx108.
doi: 10.1093/omcr/omx108. eCollection 2018 Mar.

Life-threatening hemoptysis: case of Osler-Weber-Rendu Syndrome

Affiliations
Case Reports

Life-threatening hemoptysis: case of Osler-Weber-Rendu Syndrome

Ricardo Alicea-Guevara et al. Oxf Med Case Reports. .

Abstract

Hereditary haemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, is a rare autosomal dominant vascular disorder. Patients with HHT may present with a wide spectrum of clinical manifestations, some considered to be life-threatening. We present the case of a 53-year-old male who presented with massive haemoptysis. Chest computed tomography scan was remarkable for a large anterior, left lower lobe arteriovenous malformation. The patient underwent a pulmonary angiogram with embolization of a large left lung arteriovenous malformation, which proved to be successful in controlling the bleeding.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Multiple mucosal hemorrhagic telangiectasias, more prominent on the right lateral aspect of the tongue
Figure 2:
Figure 2:
Chest computer tomography shows left lower lung pulmonary AVM (black circle)
Figure 3:
Figure 3:
Pre-embolectomy fluoroscopy image showing afferent artery with the presence of aneurysm with feeding effect
Figure 4:
Figure 4:
Post-embolectomy fluoroscopy image showing afferent artery without signs of perfusion or feeding
Figure 5:
Figure 5:
Chest computer tomography showing status post-embolectomy of pulmonary AVM (black circle)

Similar articles

Cited by

References

    1. Shovlin CL. Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev 2010;24:203 DOI:10.1016/j.blre.2010.07.001. - DOI - PubMed
    1. Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD, et al. . International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 2011;48:73–87. DOI:10.1136/jmg.2009.069013. - DOI - PubMed
    1. Lacombe P, Lacout A, Marcy PY, Binsse S, Sellier J, Bensalah M, et al. . Diagnosis and treatment of pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: an overview. Diagn Interv Imaging 2013;94:835 DOI:10.1016/j.diii.2013.03.014. - DOI - PubMed
    1. Trembath RC, Thomson JR, Machado RD, Morgan NV, Atkinson C, Winship I, et al. . Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2001;345:325–34. DOI:10.1056/NEJM200108023450503. - DOI - PubMed
    1. Cottin V, Chinet T, Lavolé A, Corre R, Marchand E, Reynaud-Gaubert M, et al. . Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: a series of 126 patients. Medicine (Baltimore) 2007;86:1–17. DOI:10.1097/MD.0b013e31802f8da1. - DOI - PubMed

Publication types

LinkOut - more resources